A Randomized Phase II Study Assessing the Efficacy of Local Consolidative Therapy for Non-Small Cell Lung Cancer Patients With Oligometastatic Disease
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Bevacizumab; Crizotinib; Erlotinib; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Mar 2020 Biomarkers information updated
- 20 Jun 2013 New source identified and integrated (M.D. Anderson Cancer Center record, 2012-0618).
- 17 Dec 2012 New trial record